ZA981791B - Chemical compound. - Google Patents

Chemical compound.

Info

Publication number
ZA981791B
ZA981791B ZA9801791A ZA981791A ZA981791B ZA 981791 B ZA981791 B ZA 981791B ZA 9801791 A ZA9801791 A ZA 9801791A ZA 981791 A ZA981791 A ZA 981791A ZA 981791 B ZA981791 B ZA 981791B
Authority
ZA
South Africa
Prior art keywords
chemical compound
chemical
compound
Prior art date
Application number
ZA9801791A
Other languages
English (en)
Inventor
Zadeo Cimarosti
Paolo Maragni
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ZA981791B publication Critical patent/ZA981791B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
ZA9801791A 1997-03-05 1998-03-03 Chemical compound. ZA981791B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
ZA981791B true ZA981791B (en) 1999-09-03

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9801791A ZA981791B (en) 1997-03-05 1998-03-03 Chemical compound.

Country Status (29)

Country Link
EP (1) EP0966463A1 (et)
JP (1) JP2001513796A (et)
KR (1) KR20000075907A (et)
CN (1) CN1249750A (et)
AP (1) AP9901637A0 (et)
AR (1) AR011178A1 (et)
AU (1) AU6825198A (et)
BG (1) BG103779A (et)
BR (1) BR9808305A (et)
CA (1) CA2282851A1 (et)
CO (1) CO4940415A1 (et)
EA (1) EA199900710A1 (et)
EE (1) EE9900387A (et)
GB (1) GB9704498D0 (et)
HR (1) HRP980114A2 (et)
HU (1) HUP0002109A2 (et)
ID (1) ID24207A (et)
IL (1) IL131489A0 (et)
IS (1) IS5166A (et)
NO (1) NO994303L (et)
NZ (1) NZ337315A (et)
OA (1) OA11154A (et)
PE (1) PE51399A1 (et)
PL (1) PL335652A1 (et)
SK (1) SK119699A3 (et)
TR (1) TR199902117T2 (et)
WO (1) WO1998039327A1 (et)
YU (1) YU43499A (et)
ZA (1) ZA981791B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (ru) 2017-06-12 2021-07-13 Глитек Ллс. Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
PE51399A1 (es) 1999-06-07
IL131489A0 (en) 2001-01-28
NO994303L (no) 1999-11-03
EA199900710A1 (ru) 2000-04-24
BR9808305A (pt) 2000-05-16
EE9900387A (et) 2000-04-17
ID24207A (id) 2000-07-13
HUP0002109A2 (hu) 2001-04-28
SK119699A3 (en) 2000-05-16
IS5166A (is) 1999-08-27
PL335652A1 (en) 2000-05-08
TR199902117T2 (xx) 2000-03-21
AU6825198A (en) 1998-09-22
OA11154A (en) 2003-04-16
CN1249750A (zh) 2000-04-05
NZ337315A (en) 2001-02-23
BG103779A (en) 2000-06-30
HRP980114A2 (en) 1998-12-31
JP2001513796A (ja) 2001-09-04
KR20000075907A (ko) 2000-12-26
EP0966463A1 (en) 1999-12-29
NO994303D0 (no) 1999-09-03
GB9704498D0 (en) 1997-04-23
CO4940415A1 (es) 2000-07-24
AP9901637A0 (en) 1999-09-30
CA2282851A1 (en) 1998-09-11
WO1998039327A1 (en) 1998-09-11
AR011178A1 (es) 2000-08-02
YU43499A (sh) 2000-12-28

Similar Documents

Publication Publication Date Title
ZA9810125B (en) Chemical compounds.
ZA971645B (en) Chemical compounds.
ZA9710314B (en) Chemical compounds.
ZA975953B (en) Chemical compounds.
GB9705361D0 (en) Chemical compounds
GB9704208D0 (en) Chemical compounds
ZA975436B (en) Chemical Compounds.
ZA975951B (en) Chemical compounds.
GB9708530D0 (en) Chemical compounds
ZA991841B (en) Chemical Compounds.
ZA991032B (en) Chemical compounds.
ZA981893B (en) Chemical composition.
ZA981791B (en) Chemical compound.
GB9703201D0 (en) Chemical compounds
GB9708119D0 (en) Chemical compounds
GB9705212D0 (en) Chemical compounds
ZA977189B (en) Supported chemical compound.
ZA99688B (en) Chemical compounds.
GB9706707D0 (en) Chemical compounds
ZA981876B (en) Chemical compounds.
GB9711994D0 (en) Chemical compounds
GB9725602D0 (en) Chemical compound
GB9719002D0 (en) Chemical compound
GB9705796D0 (en) Chemical compound
GB9703350D0 (en) Chemical compound